ARTICLE | Clinical News
sNN0029 regulatory update
November 16, 2009 8:00 AM UTC
EMEA's Committee for Orphan Medicinal Products (COMP) issued a positive opinion to grant Orphan Drug designation for NeuroNova's sNN0029 to treat amyotrophic lateral sclerosis (ALS). The vascular end...